HLE Glascoat Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 3:14 pm

Competitors of HLE Glascoat Ltd

All Competitor Stocks of HLE Glascoat Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:45 pm

Below is a detailed analysis of the quarterly data for HLE Glascoat Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 284.00 Cr.. The value appears to be declining and may need further review. It has decreased from 334.00 Cr. (Mar 2025) to 284.00 Cr., marking a decrease of 50.00 Cr..
• For Expenses, as of Jun 2025, the value is 246.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 282.00 Cr. (Mar 2025) to 246.00 Cr., marking a decrease of 36.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 52.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 14.00 Cr..
• For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 13.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Interest, as of Jun 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 14.00 Cr..
• For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be increasing, which may not be favorable. It has increased from 15.00% (Mar 2025) to 22.00%, marking an increase of 7.00%.
• For Net Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 14.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.16. The value appears to be declining and may need further review. It has decreased from 2.98 (Mar 2025) to 2.16, marking a decrease of 0.82.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:08 am

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for HLE Glascoat Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 9.05. This value is within the healthy range. It has increased from 5.99 (Mar 24) to 9.05, marking an increase of 3.06.
• For Diluted EPS (Rs.), as of Mar 25, the value is 9.05. This value is within the healthy range. It has increased from 5.99 (Mar 24) to 9.05, marking an increase of 3.06.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.39. This value is within the healthy range. It has increased from 9.84 (Mar 24) to 13.39, marking an increase of 3.55.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 67.28. It has decreased from 70.93 (Mar 24) to 67.28, marking a decrease of 3.65.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 67.28. It has decreased from 70.93 (Mar 24) to 67.28, marking a decrease of 3.65.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 150.53. It has increased from 141.79 (Mar 24) to 150.53, marking an increase of 8.74.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 20.64. This value is within the healthy range. It has increased from 17.71 (Mar 24) to 20.64, marking an increase of 2.93.
• For PBIT / Share (Rs.), as of Mar 25, the value is 16.30. This value is within the healthy range. It has increased from 13.85 (Mar 24) to 16.30, marking an increase of 2.45.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.00. This value is within the healthy range. It has increased from 8.60 (Mar 24) to 11.00, marking an increase of 2.40.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 9.05. This value is within the healthy range. It has increased from 5.99 (Mar 24) to 9.05, marking an increase of 3.06.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.58. This value is within the healthy range. It has increased from 4.35 (Mar 24) to 6.58, marking an increase of 2.23.
• For PBDIT Margin (%), as of Mar 25, the value is 13.71. This value is within the healthy range. It has increased from 12.48 (Mar 24) to 13.71, marking an increase of 1.23.
• For PBIT Margin (%), as of Mar 25, the value is 10.82. This value is within the healthy range. It has increased from 9.77 (Mar 24) to 10.82, marking an increase of 1.05.
• For PBT Margin (%), as of Mar 25, the value is 7.30. This value is below the healthy minimum of 10. It has increased from 6.06 (Mar 24) to 7.30, marking an increase of 1.24.
• For Net Profit Margin (%), as of Mar 25, the value is 6.01. This value is within the healthy range. It has increased from 4.22 (Mar 24) to 6.01, marking an increase of 1.79.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.37. This value is below the healthy minimum of 8. It has increased from 3.06 (Mar 24) to 4.37, marking an increase of 1.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.78. This value is below the healthy minimum of 15. It has increased from 7.34 (Mar 24) to 9.78, marking an increase of 2.44.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 13.23 (Mar 24) to 15.34, marking an increase of 2.11.
• For Return On Assets (%), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has increased from 2.46 (Mar 24) to 3.47, marking an increase of 1.01.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has decreased from 0.36 (Mar 24) to 0.23, marking a decrease of 0.13.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.76. This value is within the healthy range. It has decreased from 0.89 (Mar 24) to 0.76, marking a decrease of 0.13.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.82. It has decreased from 0.92 (Mar 24) to 0.82, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 1.5. It has decreased from 1.27 (Mar 24) to 1.14, marking a decrease of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.63 (Mar 24) to 0.49, marking a decrease of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 4. It has decreased from 1.56 (Mar 24) to 1.46, marking a decrease of 0.10.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 25.29 (Mar 24) to 0.00, marking a decrease of 25.29.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 13.40 (Mar 24) to 0.00, marking a decrease of 13.40.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 74.71 (Mar 24) to 0.00, marking a decrease of 74.71.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.60 (Mar 24) to 0.00, marking a decrease of 86.60.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.89. This value is within the healthy range. It has decreased from 3.95 (Mar 24) to 3.89, marking a decrease of 0.06.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 3. It has increased from 2.51 (Mar 24) to 2.71, marking an increase of 0.20.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,096.95. It has decreased from 3,183.84 (Mar 24) to 2,096.95, marking a decrease of 1,086.89.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.04. This value is within the healthy range. It has decreased from 3.29 (Mar 24) to 2.04, marking a decrease of 1.25.
• For EV / EBITDA (X), as of Mar 25, the value is 14.88. This value is within the healthy range. It has decreased from 26.34 (Mar 24) to 14.88, marking a decrease of 11.46.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 1.66, marking a decrease of 1.22.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 74.70 (Mar 24) to 0.00, marking a decrease of 74.70.
• For Price / BV (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 6.89 (Mar 24) to 3.71, marking a decrease of 3.18.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 1.66, marking a decrease of 1.22.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness